Provided by Tiger Trade Technology Pte. Ltd.

Axsome Therapeutics

207.77
-0.2600-0.12%
Post-market: 207.770.00000.00%19:30 EDT
Volume:734.95K
Turnover:153.13M
Market Cap:10.88B
PE:-55.13
High:210.87
Open:207.22
Low:206.50
Close:208.03
52wk High:260.19
52wk Low:112.90
Shares:52.38M
Float Shares:43.83M
Volume Ratio:1.37
T/O Rate:1.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7685
EPS(LYR):-3.6821
ROE:-245.10%
ROA:-16.31%
PB:130.64
PE(LYR):-56.43

Loading ...

Mar 19, 2024

Major Issues Report

Form 8-K - Current report
Mar 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 23, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 20, 2024

Major Issues Report

Form 8-K - Current report
Feb 20, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Jan 04, 2024

Major Issues Report

Form 8-K - Current report
Dec 08, 2023

Major Issues Report

Form 8-K - Current report
Nov 06, 2023

Major Issues Report

Form 8-K - Current report
Nov 06, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 12, 2023

Major Issues Report

Form 8-K - Current report
Sep 16, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 15, 2023

Major Issues Report

Form 8-K - Current report
Aug 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2023

Major Issues Report

Form 8-K - Current report
Aug 04, 2023

Major Issues Report

Form 8-K - Current report